This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease

Sponsored by CardioDx

About this trial

Last updated 6 years ago

Study ID

CDX_000013

Status

Completed

Type

Observational

Placebo

No

Accepting

18-75 Years
21+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 12 years ago

What is this trial about?

The objective of this study is to collect data on the commercial use of Corus CAD (Age/Sex/Gene Expression score - ASGES) blood test to evaluate the clinical referral patterns of Primary Care Physicians after receipt of their patients' Corus Score, and to better understand patient management patterns for clinicians ordering the test.

What are the participation requirements?

Yes

Inclusion Criteria

1. Patients with symptoms suggestive of CAD, including typical or atypical angina or angina equivalent

2. The patient has signed the appropriate Institutional Review Board approved Informed Consent Form

No

Exclusion Criteria

1. History of myocardial infarction

2. Current MI or acute coronary syndrome

3. Current New York Heart Association (NYHA) class III or IV congestive heart failure symptoms

4. Any previous coronary Revascularization

5. Any individuals with:

- Diabetes
- Suspected unstable angina
- Systemic infections
- Systemic inflammatory conditions

6. Any individuals currently taking:

- Steroids
- Immunosuppressive agents
- Chemotherapeutic agents

7. Recipient of any organ transplant

Locations

Location

Status